ArticleProceedings of the National Academy of Sciences of the United States of America2025
A unified model of transient poration induced by antimicrobial peptides.
Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Programmable 4D printing of sustainable multifunctional photoresins with tissue-matched mechanics for interfacial tissue regeneration.Bioactive materials · 2027Article
- Article
- Retracing the origin and evolution of a cryptic antimicrobial peptide within mammalian lactoferrin.PLoS biology · 2026Article
- Advances in molecular dynamics approaches for investigating cell-penetrating peptides.Biophysical reviews · 2026Review
- Serendipitous Hinge Modulation Hypothetically Reprograms Caerin 1.1-LC Antibacterial Mechanism and Gram-Negative Selectivity.Pharmaceutics · 2025Article
- Structures, Interactions, and Antimicrobial Activity of the Shortest Thanatin Peptide fromInternational journal of molecular sciences · 2025Article
- A unified model of transient poration induced by antimicrobial peptides.Proceedings of the National Academy of Sciences of the United States of America · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Membrane active peptides (MAPs) represent a diverse group of agents that disrupt the integrity of lipid membranes. One class of MAPs, antimicrobial peptides (AMPs), destroy bacteria by transiently porating the bacterial membrane causing leakage of cellular contents. Transient leakage is classified as "graded," where all vesicles in a population leak partially, or "all-or-none," where some vesicles leak completely. However, the molecular interactions underlying transient leakage have eluded experimental determination. Here, dye leakage experiments with the AMP piscidin 1 (P1) show that graded leakage can be converted to all-or-none by simply adding a defect-promoting lysophospholipid. Molecular dynamics simulations demonstrate that area stress arising from membrane asymmetry decreases the energy of pore formation and is highly lipid dependent. Furthermore, lipids and peptides translocate the bilayer through these pores, leading to area-relaxed states where poration is highly unfavorable. Even pores too small to leak dye relieve area stress; they are the "none" component of all-or-none release. These observations lead to development of a quantitative model where graded and all-or-none leakage are treated as a continuum explained by a single mechanism that accounts for the local peptide concentration and probabilities of different pore sizes. This unified model accurately reproduces the P1 dye leakage data and provides an explanation for varying pore energy, size, and probability within the framework of asymmetry-driven poration. This model is expected to be applicable to other MAPs, including cell-penetrating peptides, and could provide a framework for designing peptides with greater cellular specificity, a long-sought outcome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.